Crohn Disease: When Infliximab Fails, a Customized Algorithm May Succeed

Rather than merely intensifying the infliximab dose in response to loss of therapeutic effect, a Danish treatment algorithm tailors subsequent therapy based on drug bioavailability and pharmacodynamics.
Source: Consultant Live - Category: Primary Care Source Type: news